Compass Planning Associates Inc Acquires Shares of 6,153 LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Compass Planning Associates Inc bought a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 6,153 shares of the medical instruments supplier’s stock, valued at approximately $567,000. LeMaitre Vascular makes up about 0.6% of Compass Planning Associates Inc’s portfolio, making the stock its 19th largest holding.

A number of other large investors have also made changes to their positions in the company. New York State Teachers Retirement System lifted its position in shares of LeMaitre Vascular by 1.2% in the fourth quarter. New York State Teachers Retirement System now owns 8,189 shares of the medical instruments supplier’s stock worth $755,000 after purchasing an additional 100 shares in the last quarter. Shaker Investments LLC OH lifted its position in LeMaitre Vascular by 0.8% in the 4th quarter. Shaker Investments LLC OH now owns 13,948 shares of the medical instruments supplier’s stock worth $1,285,000 after buying an additional 112 shares in the last quarter. Sanctuary Advisors LLC lifted its position in LeMaitre Vascular by 6.0% in the 4th quarter. Sanctuary Advisors LLC now owns 2,065 shares of the medical instruments supplier’s stock worth $207,000 after buying an additional 117 shares in the last quarter. Glenmede Trust Co. NA boosted its stake in shares of LeMaitre Vascular by 1.3% during the 3rd quarter. Glenmede Trust Co. NA now owns 10,512 shares of the medical instruments supplier’s stock valued at $976,000 after buying an additional 136 shares during the period. Finally, Summit Global Investments grew its holdings in shares of LeMaitre Vascular by 2.4% during the 3rd quarter. Summit Global Investments now owns 6,192 shares of the medical instruments supplier’s stock valued at $575,000 after acquiring an additional 146 shares in the last quarter. Institutional investors and hedge funds own 84.64% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on LMAT. Barrington Research upped their target price on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a research report on Friday, November 1st. Wells Fargo & Company started coverage on shares of LeMaitre Vascular in a research report on Thursday, February 13th. They set an “equal weight” rating and a $95.00 price objective on the stock. StockNews.com downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Friday, December 13th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $93.00 price objective (up previously from $90.00) on shares of LeMaitre Vascular in a research note on Friday, November 1st. Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $94.63.

LeMaitre Vascular Price Performance

LeMaitre Vascular stock opened at $100.92 on Friday. The firm has a market cap of $2.27 billion, a price-to-earnings ratio of 55.15, a P/E/G ratio of 2.27 and a beta of 0.96. The firm has a fifty day moving average price of $96.05 and a two-hundred day moving average price of $93.97. LeMaitre Vascular, Inc. has a fifty-two week low of $59.87 and a fifty-two week high of $109.58.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.